Administration Warns States Against Limiting Costly Hepatitis C Drugs In Medicaid Programs

The federal officials also sent letters to drug makers asking what efforts they have pursued to make the drugs more affordable. In other news, a look at how the powerful drug makers' lobby is responding to recent reports of price hikes, and Pfizer announces it is increasing its drug assistance program for patients.